Flavone initiates a hierarchical activation of the caspase-cascade in colon cancer cells

Apoptosis

Volumn 10, Issue 3, 2005, Pages 611-617

  Erhart, L M ^a   Lankat Buttgereit, B ^a   Schmidt, H ^a   Wenzel, U ^b   Daniel, H ^b   Goke R ^a,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Apoptosis; Apoptosis inducing factor; Caspase; Colon cancer; Flavone

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; FLAVONE; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASES; CELL CYCLE; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; FLAVOPROTEINS; HCT116 CELLS; HUMANS; MEMBRANE PROTEINS;

EID: 21244502193     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10495-005-1895-y     Document Type: Article

References (41)

1. Stein CJ, Colditz GA. Modifiable risk factors for cancer. Br J Cancer 2004; 90: 299-303.
2. Potter JD. Risk factors for colon neoplasia - epidemiology and biology. Eur J Cancer 1995; 31A: 1033-1038.
3. Slattery ML, Potter JD, Friedman GD, Ma KN, Edwards S. Tobacco use and colon cancer. Int J Cancer 1997; 70: 259-264.
4. Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol 1998; 148: 4-16.
5. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: A review of the epidemiology. Epidemiol Rev 1993; 15: 499-545.
6. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol 1994; 139: 1-15.
7. Johnson IT. New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat Res 2004; 551: 9-28.
8. Witte JS, Longnecker MP, Bird CL, et al. Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps. Am J Epidemiol 1996; 144: 1015-1025.
9. Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997; 146: 223-230.
10. Peterson J, Dwyer J. Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. J Am Diet Assoc 1998; 98: 677-682, 685; quiz 683-684.
11. Duthie SJ, Dobson VL. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur J Nutr 1999; 38: 28-34.
12. Williamson G, Faulkner K, Plumb GW. Glucosinolates and phenolics as antioxidants from plant foods. Eur J Cancer Prev 1998; 7: 17-21.
13. Calomme M, Pieters L, Vlietinck A, Vanden Berghe D. Inhibition of bacterial mutagenesis by Citrus flavonoids. Planta Med 1996; 62: 222-226.
14. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD. Flavonoids activate wild-type p53. Oncogene 1996; 13: 1605-1614.
15. Gerritsen ME. Flavonoids: Inhibitors of cytokine induced gene expression. Adv Exp Med Biol 1998; 439: 183-190.
16. Cova D, De Angelis L, Giavarini F, Palladini G, Perego R. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1992; 30: 29-33.
17. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994; 124: 825-832.
18. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 1998; 67: 867-872.
19. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995; 62: 1276-1282.
20. Kuo SM. Transepithelial transport and accumulation of flavone in human intestinal Caco-2 cells. Life Sci 1998; 63: 2323-2331.
21. Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 2000; 60: 3823-3831.
22. Herzog A, Kindermann B, Doring F, Daniel H, Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics 2004; 4: 2455-2464.
23. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. Embo J 1998; 17: 1675-1687.
24. Ozoren N, El-Deiry WS. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Neoplasia 2002; 4: 551-557.
25. Lin CF, Chen CL, Chang WT, et al. Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide and etoposide-induced apoptosis. J Biol Chem 2004; 279: 40755-40761. Epub 2004 Jul 15.
26. Hirata H, Takahashi A, Kobayashi S, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 1998; 187: 587-600.
27. Talanian RV, Quinlan C, Trautz S, et al. Substrate specificities of caspase family proteases. J Biol Chem 1997; 272: 9677-9682.
28. Daugas E, Susin SA, Zamzami N, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. Faseb J 2000; 14: 729-739.
29. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
30. Slee EA, Harte MT, Kluck RM, et al. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144: 281-292.
31. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002; 297: 1352-1354.
32. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002; 277: 13430-13437. Epub 2002 Feb 06.
33. Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277: 29803-29809.
34. Wagner KW, Engels IH, Deveraux QL. Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway. J Biol Chem 2004; 279: 35047-35052. Epub 2004 Jun 01.
35. Enoksson M, Robertson JD, Gogvadze V, et al. Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids. J Biol Chem 2004; 8: 8.
36. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381-394.
37. Baliga BC, Read SH, Kumar S. The biochemical mechanism of caspase-2 activation. Cell Death Differ 2004; 11: 1234-1241.
38. Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002; 7: 313-319.
39. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003; 193: 10-21.
40. Martinon F, Tschopp J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574.
41. + -mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Biophys Res Commun 2004; 321: 462-467.